Barbiturates act as central nervous system depressants by enhancing GABA-A receptor inhibitory neurotransmission, which reduces neuronal excitability and potentially interrupts the pathological pain signaling associated with cluster headaches. When administered, they can provide rapid sedation and analgesic effects, potentially breaking the cycle of intense pain characteristic of cluster headache episodes by modulating neuronal activity and reducing central pain perception.